About Centylebiotech
Centylebiotech is a Healthcare company. It offers next-generation sequencing, proteomics, metabolomics, and agricultural solutions. It operates on a B2B and D2C model in Healthcare and Agriculture sectors. Its Indian entity Centyle Biotech Private Limited reported revenue of ₹1.01 Cr. Centylebiotech offers products and services including DNA Sequencing Services, RNA Sequencing Services, Proteomics Services, Biofertilizer, and Plant Probiotics. Its focus areas include Life Sciences, Biotech, Genomics and Next Generation Sequencing.
Company details
Centyle Biotech specializes in advanced multi-omics services, including next-generation sequencing, proteomics, and metabolomics analysis, to support research in genomics and personalized medicine. They also supply biotech products like biofertilizers and plant probiotics for sustainable agriculture. Based in India, with offices in New Delhi and Rudrapur, the company serves researchers, healthcare professionals, and farmers through contract services and product sales, focusing on innovation and quality in life sciences.
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Website centylebiotech.com
- Social X Facebook
- Legal Name Centyle Biotech Pvt Ltd
- Date of Incorporation 01 Nov, 2018
- Jurisdiction Rudrapur, Uttarakhand, India
- Indian entity revenue₹1.01 Cr
FY 2025 · +92% YoY
- Indian entity net profit₹4.5 Lakh
FY 2025 · 4% margin
- Indian entity EBITDA₹6.5 Lakh
FY 2025 · 6% margin
Associated legal entities of Centylebiotech
Centylebiotech operates through Centyle Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Centyle Biotech Private Limited CIN U01100UR2018PTC009185 | Active | 01 Nov 2018 | Rudrapur, Uttarakhand | ₹1.0 Cr | 2 | View details |
Products & Services of Centylebiotech
Centylebiotech offers a comprehensive portfolio of products and services, including DNA Sequencing Services, RNA Sequencing Services, Proteomics Services, Biofertilizer, and Plant Probiotics.
Provides sequencing of DNA for research and analysis purposes.
Offers sequencing of RNA to study gene expression patterns.
Analyzes proteins to understand biological functions and interactions.
Enhances soil fertility and supports sustainable crop growth.
Improves plant health and ecosystem through microbial support.
Board of directors of Centyle Biotech Private Limited (Centylebiotech)
Centyle Biotech Private Limited is the primary company behind Centylebiotech. The board of Centyle Biotech Private Limited currently have 2 directors; the longest-serving is Indrajeet Mandal, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Indrajeet Mandal DIN 08271949 | Director | 01 Nov 2018 | 8 yrs | Centyle Biotech Private Limited |
| Piyush Tiwari Kumar DIN 08262652 | Director | 07 Jul 2020 | 6 yrs 4 mo | Centyle Biotech Private Limited |
People of Centylebiotech
1 people are tracked at Centylebiotech (1 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for Centylebiotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Centylebiotech
Figures of Centyle Biotech Private Limited, the primary company behind Centylebiotech, for FY 2025. Revenue was ₹1.01 Cr (+92% year on year). Net profit was ₹4.5 Lakh (4% margin). EBITDA was ₹6.5 Lakh (6% margin). Revenue has grown at a compounded annual rate of +39% over three years and +161% over five years.
- ₹1.01 CrRevenue · FY 2025 · +92% YoY
- ₹4.5 LakhNet profit · 4% margin
- ₹6.5 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- +39%Revenue CAGR, 3 years
- +161%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Centyle Biotech Private Limited are on its company page.
Detailed financial statements for Centylebiotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Centylebiotech
The primary company behind Centylebiotech, Centyle Biotech Private Limited, reported revenue of ₹1.01 Cr for FY 2025, up 92% year on year.
Centyle Biotech specializes in advanced multi-omics services, including next-generation sequencing, proteomics, and metabolomics analysis, to support research in genomics and personalized medicine. They also supply biotech products like biofertilizers and plant probiotics for sustainable agriculture. Based in India, with offices in New Delhi and Rudrapur, the company serves researchers, healthcare professionals, and farmers through contract services and product sales, focusing on innovation and quality in life sciences.
Centylebiotech offers DNA Sequencing Services, RNA Sequencing Services, Proteomics Services, Biofertilizer, and Plant Probiotics.
Centylebiotech operates through Centyle Biotech Private Limited.
The legal entities of Centylebiotech currently have 2 directors, including Piyush Tiwari Kumar, Indrajeet Mandal.